Related Experiment Video
Updated: Oct 9, 2026

Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development
Published on: June 19, 2018
Differences in reactogenicity and antigenicity of acellular and standard pertussis vaccines combined with diphtheria
E L Anderson1, R B Belshe, J Bartram
1Department of Medicine, Marshall University School of Medicine, Huntington, West Virginia 25701.
Insights
The acellular pertussis vaccine (DTP-AC) showed fewer side effects in infants compared to the whole-cell diphtheria-tetanus-pertussis vaccine (DTP-WC). DTP-AC also demonstrated strong immunogenicity, making it a potentially safer alternative for infant immunization.
Area of Science:
- Pediatrics
- Immunology
- Vaccinology
Background:
- Infant immunization relies on effective vaccines like diphtheria-tetanus-pertussis (DTP).
- Whole-cell DTP (DTP-WC) vaccines have been associated with significant local and systemic reactions.
- Acellular pertussis components, including lymphocytosis-promoting factor (LPF) and filamentous hemagglutinin (FHA), offer potential for reduced reactogenicity.
Purpose of the Study:
- To compare the clinical and serological responses of infants to primary immunization with an acellular pertussis DTP vaccine (DTP-AC) versus a whole-cell DTP vaccine (DTP-WC).
Main Methods:
- A double-blind study involving 19 infants receiving DTP-AC and 20 infants receiving DTP-WC.
- Three doses administered at two, four, and six months of age.
- Evaluation of clinical reactions (fever, swelling, total reactions) and antibody titers (LPF, FHA, pertussis agglutination).
Main Results:
- Infants receiving DTP-WC experienced significantly more fever, swelling, and overall reactions compared to those receiving DTP-AC.
- DTP-AC elicited comparable LPF antibody titers and significantly higher FHA antibody titers post-immunization.
- DTP-WC stimulated higher pertussis agglutination titers, but DTP-AC demonstrated superior immunogenicity and significantly reduced reactogenicity.
Conclusions:
- The acellular pertussis DTP vaccine (DTP-AC) is both immunogenic and significantly less reactogenic in infants compared to the currently used whole-cell DTP vaccine (DTP-WC).
- DTP-AC represents a potentially safer and effective option for infant pertussis immunization programs.
Abstract:
Clinical and serological responses of infants to primary immunization with diphtheria-tetanus-pertussis (DTP) vaccine containing components of acellular pertussis vaccine (DTP-AC) were compared in a double-blind study with responses of infants receiving whole-cell DTP vaccine (DTP-WC). Three doses of either DTP-AC containing lymphocytosis-promoting factor (LPF) and filamentous hemagglutinin (FHA) or DTP-WC vaccine were given to infants at two, four, and six months of age. Nineteen infants received DTP-AC vaccine, and 20 infants received DTP-WC vaccine. Significantly more infants who received DTP-WC vaccine manifested fever, swelling, and/or total reactions than did infants who received DTP-AC vaccine. Infants who received DTP-AC vaccine had comparable antibody titers to LPF and significantly higher titers to FHA after three immunizations, as compared with the infants who received DTP-WC vaccine (P less than or equal to .001). The DTP-WC vaccine stimulated higher pertussis agglutination titers (P = .04) than did DTP-AC. The DTP-AC vaccine was immunogenic and significantly less reactogenic in infants than was the currently used DTP-WC vaccine.
Related Concept Videos
Cross-reactivity
Vaccinations
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Active versus Passive Immunity
Active Immunity
Active immunity refers to the resistance one develops...
Vaccines
Diphtheria

